| Literature DB >> 31327258 |
Hiroki Kobayashi1,2,3, Masanori Abe1, Yoshihiro Nakamura1, Katsutoshi Takahashi4,5, Megumi Fujita5, Yoshiyu Takeda6, Takashi Yoneda6, Isao Kurihara7, Hiroshi Itoh7, Mika Tsuiki8, Norio Wada9, Takamasa Ichijo10, Takuyuki Katabami11, Yoshihiro Ogawa12, Junji Kawashima13, Takanobu Yoshimoto12, Masakatsu Sone14, Nobuya Inagaki14, Minemori Watanabe15, Kohei Kamemura16, Yuichi Matsuda17, Shoichiro Izawa18, Makito Tanabe19, Akiyo Tanabe20, Tomoko Suzuki21, Mitsuhide Naruse8.
Abstract
Primary aldosteronism causes renal structural damage after glomerular hyperfiltration, and primary aldosteronism-specific treatment leads to an acute fall in estimated glomerular filtration rate (eGFR). We investigated whether this change affected the long-term eGFR slope in a retrospective cohort from the multicenter Japan Primary Aldosteronism Study. We allocated patients with primary aldosteronism to the adrenalectomy (n=202) and MR (mineralocorticoid receptor) antagonist (n=303) groups based on their treatment history and analyzed the association between the initial eGFR fall and long-term eGFR slope. The increased age, low serum potassium levels, high eGFR, and high plasma aldosterone levels were independent predictors for a large initial eGFR fall in both groups. Our analysis of tertiles based on the initial eGFR fall revealed that in the MR antagonist group, patients with a small initial eGFR fall had a significantly steeper long-term eGFR slope than those with a large initial fall (tertile 1 versus 2, P=0.025; tertile 1 versus 3, P=0.017). These associations were not identified in the adrenalectomy group. Thus, the smaller the acute fall in eGFR by initiation of MR antagonists, the greater was the rate of long-term eGFR decline. While the acute fall in eGFR induced by primary aldosteronism-specific treatment is occasionally a clinical concern, our findings highlight the favorable implications of the acute fall with respect to long-term renal outcomes.Entities:
Keywords: adrenalectomy; aldosterone; glomerular filtration rate; hyperaldosteronism; kidney
Mesh:
Substances:
Year: 2019 PMID: 31327258 DOI: 10.1161/HYPERTENSIONAHA.119.13131
Source DB: PubMed Journal: Hypertension ISSN: 0194-911X Impact factor: 10.190